Why the study?
Many cancer therapies significantly affect cardiovascular health, prompting an examination of current interdisciplinary cardio-oncology clinical care delivery and education in the United States.
Cross-Sectional
Yes
A nationwide US survey of cardiology chiefs and program directors highlights significant interest in cardio-oncology but identifies lack of guidelines, funding, and infrastructure as major barriers to its development.
Many existing and emerging cancer therapies have a significant effect on the cardiovascular health of patients with cancer and cancer survivors. This paper examines current aspects of interdisciplinary cardio-oncology clinical care delivery and education in the United States and outlines how these data provide a platform for future development of the field. We present the results of the nationwide survey on cardio-oncology services, practices, and opinions, conducted among chiefs of cardiology and program directors, which demonstrate ranges of clinical activities and identify significant interest for increased educational opportunities and expert training of cardiovascular physicians in this field. The survey respondents recognized clinical relevance but emphasized lack of national guidelines, lack of funds, and limited awareness and infrastructure as the main challenges for development and growth of cardio-oncology. We discuss potential solutions to unmet needs through interdisciplinary collaboration and the active roles of professional societies and other stakeholders.
No takes yet. Share an insight, caveat, or question.
Barac et al. (2015) conducted a cross-sectional in Cardiovascular health in cancer patients and survivors. Nationwide survey was evaluated on Cardio-oncology services, practices, and opinions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: